Skip to main content
Clinical Trials/ACTRN12607000338460
ACTRN12607000338460RecruitingPhase 4

A study to compare the effectiveness and safety of an oral low dose and a megadose vitamin D treatment regimens - a real-life comparison pilot study.

Prof. Peter Ebeling0 sites60 target enrollmentStarted: June 26, 2007Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 90 Years (—)
Sex
All

Inclusion Criteria

  • Serum 25(0H) concentration < 50 nmol/L and ability to consent to trial participation.

Exclusion Criteria

  • Inability to either give informed consent or complete the three month study, primary or tertiary hyperparathyroidism or other causes of hypercalcaemia.

Investigators

Sponsor
Prof. Peter Ebeling

Similar Trials